About Ruth Roberts

Professor Ruth A Roberts, PhD, ATS, FBTS, ERT, FRSB, FRCPath. A co-founder of ApconiX, Ruth has 25 years of experience in leading roles in drug safety within large pharma. Ruth is also Chair and Director of Drug Discovery at The University of Birmingham, UK and was previously Global Head of Regulatory Safety at AstraZeneca. With over 140 publications in peer-reviewed journals, she is former president of the British Toxicology Society, former president of EUROTOX, former secretary to SOT and President of the Academy of Toxicological Sciences. Ruth was the recipient of the SOT Achievement award in 2002, the EUROTOX Bo Holmstedt Award in 2009 and the SOT Founders award in 2018 for outstanding leadership in toxicology. Ruth is an established science professional bringing rigorous expert thinking to toxicology, drug discovery and drug development.

New Paper Published in Birth Defects Research

New Paper Published in Birth Defects Research Dr Jane Barber, Dr Claire Sadler and Dr Jane Stewart are among the authors of new paper published in Birth Defects Research. The Paper Malarial PI4K inhibitor induced diaphragmatic hernias in rat: Potential link with mammalian kinase inhibition Abstract Background MMV390048 is [...]

By |2022-05-10T13:57:30+01:00May 6th, 2022|Company News, Toxicology, Publications|Comments Off on New Paper Published in Birth Defects Research

Dr Kimberly Rockley’s Trip to San Diego Zoo

Dr Kimberly Rockley's Trip to San Diego Zoo After a busy time at SOT Dr Kimberly Rockley took an extra day and visited San Diego zoo. One of the biggest zoos in the world, it houses over 12,000 animals from over 650 different species! The Koala was snoozing as everyone from ApconiX wanted to [...]

By |2022-04-14T16:25:23+01:00April 14th, 2022|Events|Comments Off on Dr Kimberly Rockley’s Trip to San Diego Zoo

ApconiX Will Be Attending the British Society of Toxicology Congress 2022

ApconiX Attends British Society of Toxicology Congress 2022 Professor Ruth Roberts, Dr Laurence Bishop, Dr Kimberly Rockley, Dr Sean Hammond and Nicholas Coltman will be attending the British Society of Toxicology Congress 2022 from the 4th to 6th of April at the Hilton Newcastle in Gateshead UK. ApconiX will [...]

By |2022-03-23T11:58:12+00:00March 22nd, 2022|Company News, Toxicology, Events|Comments Off on ApconiX Will Be Attending the British Society of Toxicology Congress 2022

We’re Attending SOT 2022

ApconiX is Attending the 61st Society of Toxicology Annual Meeting and ToxExpo Professor Ruth Roberts, Dr Richard Knight, Dr Michael Morton, Dr Laurence Bishop, Dr James Sidaway, Dr Claire Sadler, Dr Kimberly Rockley, Simon Craige, and Dr Andrew Winkley will all be attending the SOT 2022 Annual Meeting and [...]

By |2022-03-11T14:46:05+00:00March 11th, 2022|Company News, Events|Comments Off on We’re Attending SOT 2022

Hopefully Attending Face-to-face Meetings in 2022

Hopefully Attending Face-to-face Meetings in 2022 Face-to-face meetings are back (hopefully!) and we can’t wait to get out there and share our science with the community. Our first meeting for 2022 is the ELRIG hot topic meeting on ion channels on March 16th with a focus on patient benefit [...]

By |2022-01-12T14:42:20+00:00January 12th, 2022|Company News|Comments Off on Hopefully Attending Face-to-face Meetings in 2022

Syngene Fireside Chat

Creating the RIGHT Toxicology Strategy: Learning from the Past to Shape the Future Syngene Fireside Chat In this 45-minute interactive virtual discussion on the topic ‘Creating the RIGHT toxicology strategy: Learning from the past to shape the future,’ we have Professor Ruth Roberts, Ph.D., ATS, FBTS, ERT, FRSB, FRCPath, [...]

By |2021-10-13T16:54:03+01:00October 13th, 2021|Company News|Comments Off on Syngene Fireside Chat

Life Science Innovation

It’s Time for Action on Sex Bias in Clinical Trials Life Science Innovation Launched 30th September 2021.  You'll find a hard copy of the publication within the New Scientist. Read the online version here Download PDF Life Science Innovation It’s Time for Action on Sex Bias in Clinical Trials [...]

By |2021-10-06T15:10:06+01:00September 30th, 2021|Company News|Comments Off on Life Science Innovation

ApconiX Exhibiting at BioForward 2021

ApconiX Exhibiting BioForward 2021 Laurence Bishop, Head of Business Development and Pauline Garner, Senior Project Manager, are looking forward to attending BioForward 2021 next week. ApconiX will be exhibiting at this event.  BioForward 2021 will take place LIVE and in-person on Thursday 23 September at The King's Centre in [...]

By |2021-09-15T14:52:40+01:00September 15th, 2021|Events|Comments Off on ApconiX Exhibiting at BioForward 2021

The Importance Of ‘Agility’

The Importance Of 'Agility' We couldn’t agree more with the 2020 Forbes Article describing Agility as the new superpower. Agility has allowed ApconiX to thrive and grow during the pandemic and to integrate new working practices into our future ways of working.  So, what does agility mean for us? Primarily, it means [...]

By |2021-09-14T10:26:11+01:00August 5th, 2021|Careers|Comments Off on The Importance Of ‘Agility’

ApconiX Welcomes Dr Sean Hammond

ApconiX Welcomes Dr Sean Hammond ApconiX is delighted to welcome Dr Sean Hammond who joins us as an Immunotoxicology Lead and is the latest addition to our growing target safety assessment team. Sean recently completed his PhD at the University of Liverpool, following on from his first degree in [...]

By |2022-01-19T13:22:58+00:00July 22nd, 2021|Company News, Careers|Comments Off on ApconiX Welcomes Dr Sean Hammond
Go to Top